Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (361-370 of 676) with videos related to

Pageof 68
Sort By:
Cancers|June 29, 2019
Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer ModelsDevalingam Mahalingam, Jennifer S Carew, Claudia M Espitia, et al.
Molecular and Cellular Biology|February 19, 2015
ShcA regulates thymocyte proliferation through specific transcription factors and a c-Abl-dependent signaling axisPaul C Trampont, Li Zhang, Amber J Giles, et al.
Oncotarget|September 12, 2015
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profilingYoung Kwang Chae, Su Yun Chung, Andrew A Davis, et al.
Cancer Genetics and Cytogenetics|February 1, 1996
Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemiaS W Lim, R E Falk, R M Look, et al.
Cancer|December 18, 2001
Response to therapy is independently associated with survival prolongation in chronic myelogenous leukemia in the blastic phaseH M Kantarjian, J Shan, T Smith, et al.
Blood|June 21, 2003
Rituximab in relapsed or refractory hairy cell leukemiaDeborah A Thomas, Susan O'Brien, Carlos Bueso-Ramos, et al.
Oncotarget|July 14, 2016
FGFR3-TACC3 fusion in solid tumors: mini reviewRicardo Costa, Benedito A Carneiro, Timothy Taxter, et al.
Scientific Reports|March 3, 2019
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinomaYoung Kwang Chae, Jonathan F Anker, Michael S Oh, et al.
Leukemia & Lymphoma|July 27, 2016
Recombinant Alpha 2A Interferon-An Effective Maintenance Agent in Essential ThrombocythaemiaF J Giles, C C Anderson, I R Grant, et al.
British Journal of Haematology|July 9, 2002
Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndromeSrdan Verstovsek, Elihu Estey, Taghi Manshouri, et al.
Pageof 68

Showing results (361-370 of 676) with videos related to

Sort By:
Pageof 68
Cancers|June 29, 2019
Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer ModelsDevalingam Mahalingam, Jennifer S Carew, Claudia M Espitia, et al.
Molecular and Cellular Biology|February 19, 2015
ShcA regulates thymocyte proliferation through specific transcription factors and a c-Abl-dependent signaling axisPaul C Trampont, Li Zhang, Amber J Giles, et al.
Oncotarget|September 12, 2015
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profilingYoung Kwang Chae, Su Yun Chung, Andrew A Davis, et al.
Cancer Genetics and Cytogenetics|February 1, 1996
Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemiaS W Lim, R E Falk, R M Look, et al.
Cancer|December 18, 2001
Response to therapy is independently associated with survival prolongation in chronic myelogenous leukemia in the blastic phaseH M Kantarjian, J Shan, T Smith, et al.
Blood|June 21, 2003
Rituximab in relapsed or refractory hairy cell leukemiaDeborah A Thomas, Susan O'Brien, Carlos Bueso-Ramos, et al.
Oncotarget|July 14, 2016
FGFR3-TACC3 fusion in solid tumors: mini reviewRicardo Costa, Benedito A Carneiro, Timothy Taxter, et al.
Scientific Reports|March 3, 2019
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinomaYoung Kwang Chae, Jonathan F Anker, Michael S Oh, et al.
Leukemia & Lymphoma|July 27, 2016
Recombinant Alpha 2A Interferon-An Effective Maintenance Agent in Essential ThrombocythaemiaF J Giles, C C Anderson, I R Grant, et al.
British Journal of Haematology|July 9, 2002
Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndromeSrdan Verstovsek, Elihu Estey, Taghi Manshouri, et al.
Pageof 68